Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors.
Journal: Research and practice in thrombosis and haemostasis
Published: February 04, 2026
Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities.
Journal: Blood vessels, thrombosis & hemostasis
Published: January 20, 2026
Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivors.
Journal: British journal of haematology
Published: August 20, 2025
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndrome.
Journal: Research and practice in thrombosis and haemostasis
Published: July 21, 2025
Standard cardiovascular risk prediction scores underestimate risk in immune-mediated thrombotic thrombocytopenic purpura survivors.
Journal: Research and practice in thrombosis and haemostasis
Published: April 15, 2025
Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy.
Journal: Blood vessels, thrombosis & hemostasis
Published: April 07, 2025
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.
Journal: Blood advances
Published: April 02, 2024
Consequences of unmet pregnancy-specific health care needs in women with immune TTP.
Journal: Blood vessels, thrombosis & hemostasis
Published: November 03, 2023
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.
Journal: Annals of hematology
Published: June 17, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026